News for 'Eli Lilly'

1 insulin price cap for all brands

1 insulin price cap for all brands

Rediff.com21 Nov 2012

Another cap for imported insulin; domestic manufacturers cry foul.

200 life-saving drugs to be cheaper

200 life-saving drugs to be cheaper

Rediff.com25 Sep 2007

The medicines whose prices have been reduced belong to therapeutic categories, like dexametozone, betamethazone, ampicillin and ranitidine. The prices of some multi-vitamins and antibiotics would rise a bit.

Pharma research outsourcing faces speed bumps

Pharma research outsourcing faces speed bumps

Rediff.com29 Jun 2010

Major drug discovery outsourcing deals have almost dried up in the past 18 months for almost all prominent players in the area

'India's patent policy is discouraging innovation'

'India's patent policy is discouraging innovation'

Rediff.com30 Mar 2010

US-based Eli Lilly has planned to continue its focus on innovation-driven products, instead of opening up to opportunities in off-patent generic drugs, being tapped by its larger competitors like GSK and Pfizer.

Modi urges global tech CEOs to be part of India growth story

Modi urges global tech CEOs to be part of India growth story

Rediff.com23 Sep 2024

Prime Minister Narendra Modi urged CEOs of US majors to take advantage of India's growth story as the country is making all efforts to become the third largest economy of the world in his third term. India is currently the fifth largest economy of the world after the US, China, Germany and Japan with a GDP of around $3.9 trillion. India has been the fastest growing large economies of the world with GDP growth rate of over 7 per cent for the last three consecutive years.

Businesses that don't exist, but should

Businesses that don't exist, but should

Rediff.com26 Dec 2007

A sampling of ideas from the next generation of consumers -- and entrepreneurs.

Ranbaxy gets nod for Fluoxetine

Ranbaxy gets nod for Fluoxetine

Rediff.com15 Dec 2004

United States' Food and Drug Administration has granted approval to Ranbaxy Laboratories Ltd to manufacture and market 40 mg capsules of Fluoxetine, a drug used in treatment of obsessive-compulsive disorders.\n\n

MNC pharma firms eyeing  duty relief

MNC pharma firms eyeing duty relief

Rediff.com28 Dec 2006

Eli Lily, Sanofi Aventis, Bristol Myers approach chemicals ministry.

How to become a great CEO

How to become a great CEO

Rediff.com27 Sep 2005

If you get stuck with business-as-usual, you get left behind.

SC to decide on tax liability of expats

SC to decide on tax liability of expats

Rediff.com31 Oct 2007

The Supreme Court will decide whether domestic companies must deduct tax at source on salaries paid to their expatriate staff and if tax can be levied on these employees on wages given abroad by foreign joint venture partners of the Indian firms.

Insulin makers cut prices

Insulin makers cut prices

Rediff.com3 Jan 2003

Leading insulin makers on Friday slashed the rates of human insulin by about 40 per cent, a move which will provide a big relief to diabetic patients.

Reddy's files with US FDA for generic Olanzapine

Reddy's files with US FDA for generic Olanzapine

Rediff.com11 Mar 2003

Drugmaker Dr Reddy's Laboratories has filed an application with the US Food and Drug Administration to market a generic form of Eli Lilly's schizophrenia drug Olanzapine in the US

Cipla ready to partner in Covid vaccine distribution

Cipla ready to partner in Covid vaccine distribution

Rediff.com17 May 2021

However, Cipla was very clear it does not want to get into vaccine manufacturing.

'Real growth and opportunity are going to come from GLP-1'

'Real growth and opportunity are going to come from GLP-1'

Rediff.com21 Aug 2024

'It is not just the US and European opportunity, but it is a huge global opportunity.'

Getting coronavirus 'a blessing in disguise': Trump

Getting coronavirus 'a blessing in disguise': Trump

Rediff.com8 Oct 2020

'I want everybody to be given the same treatment as your president because I feel great. I feel like perfect'

Novartis-Glaxo deal signals pharma firms don't have it easy

Novartis-Glaxo deal signals pharma firms don't have it easy

Rediff.com24 Apr 2014

Experts say despite it being a global deal, the transaction will have to undergo CCI scrutiny because of the scale of operations.

'The formulations business been a growth driver'

'The formulations business been a growth driver'

Rediff.com24 Feb 2024

'However, we have seen weakness in our active pharmaceutical ingredients business.'

Consumers may have to pay more for insulin

Consumers may have to pay more for insulin

Rediff.com21 Mar 2014

Apart from Wockhardt, only Biocon manufactures insulin analog indigenously.

The other desi who wowed everyone

The other desi who wowed everyone

Rediff.com20 Jan 2017

An Internet sensation, Lilly Singh worked her charm on the red carpet.

PHOTOS: The gold medallists on Day 8 at the Rio Olympics

PHOTOS: The gold medallists on Day 8 at the Rio Olympics

Rediff.com14 Aug 2016

Drysdale wins close single sculls gold Also, check out late gold medal winners from Day 7...

« Prev  |